Impact of Mindfulness Intervention on Quality of Life in Patients With Drug-resistant Epilepsy.
Recruiting · NCT04126369 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital, Grenoble
View the official record on ClinicalTrials.gov →Interventions studied
mindfulness interventionpsycho educative programme
What this trial is about
This study evaluates a mindfulness intervention in patients with drug resistant epilepsy. Half of participants will follow a mindfulness programme, while the other half will follow a self management programme.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Drug resistant epilepsy according to the criteria of the International League Against Epilepsy (ILAE)
- Stable therapy for at least 3 months
- No planned surgery
- Patient affiliated to social security insurance or beneficiary of social security insurance.
- Signed consent
Exclusion criteria
- Patient who has previously had or regularly practicing mindfulness
- Patient with psychogenic non-epileptic seizures
- Pregnant woman, breastfeeding mother, person deprived of liberty by judicial or administrative decision, person subject to legal protection
- Patient with relationship disorders related to psychosis
- Patients who are unable or unwilling to work as a group or person unable to understand the topics discussed during session.
Where it is running
3 locations listed.
- Epileptology Department of The Grenoble University Hospital - Grenoble, France
- Epileptology Department of the Lyon University Hospital - Lyon, France
- La Teppe medical centre - Tain-l'Hermitage, France